N. Horvath
About
In The Last Decade
N. Horvath
16 papers receiving 635 citations
Peers
Comparison fields: 5 of 64
- Hematology 417
- Oncology 240
- Molecular Biology 126
- Pathology and Forensic Medicine 120
- Immunology 102
Countries citing papers authored by N. Horvath
This map shows the geographic impact of N. Horvath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Horvath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Horvath more than expected).
Fields of papers citing papers by N. Horvath
This network shows the impact of papers produced by N. Horvath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Horvath. The network helps show where N. Horvath may publish in the future.
Co-authorship network of co-authors of N. Horvath
This figure shows the co-authorship network connecting the top 25 collaborators of N. Horvath. A scholar is included among the top collaborators of N. Horvath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Horvath. N. Horvath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 42 | |
| 2 | 17 | |
| 3 | 18 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 16 | |
| 9 | 75 | |
| 10 | Single dose per cycle pegfilgrastim successfully supports full dose intensity CHOP-14 in patients over 60 years with non-Hodgkin's lymphoma (NHL) and successfully mobilises peripheral blood progenitor cells (PBPC). | 5 |
| 11 | 28 | |
| 12 | 8 | |
| 13 | An incremental response to high-dose therapy in multiple myeloma. | 5 |
| 14 | Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. | 357 |
| 15 | The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. | 41 |
| 16 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.